2025
SJR Q2
JCR Q2 · 2,6
OA
6 matched articles
ESCI
Journal detail
Cardiovascular Innovations and Applications
- Publisher
- Compuscript Ltd
- Country
- Ireland · Western Europe
- Type
- journal
- ISSN
-
2009861820098782
Integrated evaluation
Scopus side is Scimago SJR; WoS side is Master Journal List + JCR/JIF. Sources are matched on ISSN. WoS / JCR metrics are available for 1997 and later years only.
WoS / JCR data covers 1997 onward.
Scopus
Scopus · Scimago
- SJR 0,526
- Quartile Q2
- H-Index 10
- Cites/doc 1,95
- Docs (3y) 178
- Cites (3y) 336
Clarivate
Web of Science · JCR · 2025
- JCR Q Q2
- JIF 2,6
- 5Y JIF 1,8
- JCI 0,38
WoS indexes
- ESCI
Subject classification
Categories (SJR)
- Cardiology and Cardiovascular Medicine Q2
Areas
- Medicine
WoS categories
- Cardiac & Cardiovascular System
Yearly quartile comparison
Scimago (SJR) for all years; Clarivate (JCR / JIF / JCI) from 1997 onward. Latest year stays open; older years start collapsed.
WoS / JCR data covers 1997 onward.
| Year | SJR Q | JCR Q (1997+) | SJR | JIF (1997+) | 5Y JIF (1997+) | JCI (1997+) | JCI Q (1997+) | H-Index |
|---|---|---|---|---|---|---|---|---|
| 2025 | Q2 | Q2 | 0,526 | 2,6 | 1,8 | 0,38 | Q3 | 10 |
| 2024 | Q3 | Q3 | 0,27 | 1,4 | 0,9 | 0,22 | Q4 | 7 |
| 2023 | — | Q4 | — | 0,9 | 0,6 | 0,15 | Q4 | 7 |
| 2022 | — | — | — | 0,5 | 0,3 | 0,06 | Q4 | 7 |
| 2021 | — | — | — | — | — | 0,03 | Q4 | 7 |
| 2020 | — | — | — | — | — | 0,04 | Q4 | 7 |
JCR category quartile history
JCR / JCI quartile by year and category. 1997 and later.
WoS / JCR data covers 1997 onward.
| Year | Category | Edition | JCR Q (1997+) | JCI Q (1997+) | Rank |
|---|---|---|---|---|---|
| 2025 | CARDIAC & CARDIOVASCULAR SYSTEMS | ESCI | Q2 | Q3 | 106/237 |
| 2024 | CARDIAC & CARDIOVASCULAR SYSTEMS | ESCI | Q3 | Q4 | 158/231 |
| 2023 | CARDIAC & CARDIOVASCULAR SYSTEMS | ESCI | Q4 | Q4 | 181/222 |
| 2022 | CARDIAC & CARDIOVASCULAR SYSTEMS | ESCI | — | Q4 | — |
| 2021 | CARDIAC & CARDIOVASCULAR SYSTEMS | ESCI | — | Q4 | — |
| 2020 | CARDIAC & CARDIOVASCULAR SYSTEMS | ESCI | — | Q4 | — |